ERYTECH Provides Business Update and Financial Highlights for Q1 2017 Post author:admERY Post published:May 18, 2017 Post category:Newsroom ERYTECH today provided a financial and business update for the first quarter of 2017 ended March 31, 2017. You Might Also Like ERYTECH Receives USPTO Notice of Allowance for Patent Covering ERYCAPS Immunotherapy Technology March 15, 2016 ERYTECH announces management change January 8, 2015 ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
ERYTECH Receives USPTO Notice of Allowance for Patent Covering ERYCAPS Immunotherapy Technology March 15, 2016
ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
